Literature DB >> 22573189

Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.

Rolando Cimaz1, Annette Von Scheven, Michael Hofer.   

Abstract

Systemic-onset juvenile idiopathic arthritis (SoJIA), sometimes called Still's disease, is a systemic inflammatory disease classified within the spectrum of juvenile idiopathic arthritis (JIA). It is an orphan disease with often a chronic course and a major impact on the affected children and their families. This disorder is unique in terms of clinical manifestations, prognosis and response to conventional immunosuppressants. The objectives of this review are to describe SoJIA and emphasise the recent advances in the pathogenesis and treatment, which have transformed the care and the prognosis of this potentially life-threatening paediatric condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573189     DOI: 10.4414/smw.2012.13582

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  Recent new drug approvals. Part 1: drugs with pediatric indications.

Authors:  Chasity M Shelton; Rebecca F Chhim; Michael L Christensen
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 2.  Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years.

Authors:  Ivona Aksentijevich
Journal:  Semin Immunopathol       Date:  2015-04-10       Impact factor: 9.623

3.  Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis.

Authors:  Mansi Dewoolkar; Rolando Cimaz; Pranav Raman Chickermane; Raju P Khubchandani
Journal:  Indian J Pediatr       Date:  2017-02-23       Impact factor: 1.967

Review 4.  Glucocorticoids in the management of systemic juvenile idiopathic arthritis.

Authors:  Gaia Vannucci; Luca Cantarini; Teresa Giani; Edoardo Marrani; Davide Moretti; Ilaria Pagnini; Gabriele Simonini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

5.  Interleukin-17A Levels Increase in Serum of Children With Juvenile Idiopathic Arthritis.

Authors:  Gordana Vijatov-Djuric; Aleksandra Doronjski; Igor Mitic; Snezana Brkic; Nenad Barisic
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.